About Kindredbio
KindredBio: Revolutionizing Veterinary Medicine
KindredBio is a leading veterinary biopharmaceutical company that is dedicated to developing innovative medicines for cats, dogs, and horses. The company was founded in 2012 and has since then been committed to improving the lives of animals through the development of safe and effective drugs.
The company's mission is to provide veterinarians with new treatment options that are specifically designed for their patients. KindredBio believes that every animal deserves access to high-quality healthcare, which is why they are constantly working on developing new drugs that can help improve the health and well-being of animals.
One of the things that sets KindredBio apart from other veterinary pharmaceutical companies is their focus on biologics. Biologics are drugs made from living organisms or their products, such as vaccines or antibodies. These types of drugs have become increasingly important in human medicine over the past few decades, but they have been slower to catch on in veterinary medicine.
KindredBio recognized this gap in the market early on and has since become a leader in developing biologic drugs for animals. Their flagship product, Zimeta (dipyrone injection), was approved by the FDA in 2016 as an intravenous treatment for fever associated with equine colic. This drug has since become a game-changer for veterinarians who treat horses with colic.
In addition to Zimeta, KindredBio has several other products in development that could revolutionize veterinary medicine. These include Mirataz (mirtazapine transdermal ointment) for cats with weight loss due to underlying medical conditions; KIND-030 (tildipirosin extended-release injectable solution) for respiratory disease in cattle; and KIND-510a (epoetin alfa-IV injection) for anemia associated with chronic kidney disease in cats.
But it's not just about developing new drugs at KindredBio – it's also about doing so responsibly. The company takes animal welfare seriously and ensures that all its products are developed using ethical practices. They also work closely with veterinarians throughout the drug development process to ensure that their products meet real-world needs.
Another thing that sets KindredBio apart from other companies is its commitment to sustainability. The company recognizes its responsibility as a corporate citizen and strives to minimize its environmental impact wherever possible. This includes reducing waste, conserving energy, and using eco-friendly materials whenever possible.
Overall, KindredBio is a forward-thinking company dedicated to improving animal health through innovation and responsible business practices. With several promising products currently under development, it's clear that this company will continue making waves within the veterinary pharmaceutical industry – all while putting animal welfare first at every step along the way!